Selecting relapsing remitting multiple sclerosis patients for treatment: the case for early treatment
J Neuroimmunol
.
1999 Jul 1;98(1):22-8.
doi: 10.1016/s0165-5728(99)00077-6.
Authors
R A Rudick
1
,
A Goodman
,
R M Herndon
,
H S Panitch
Affiliation
1
Mellen Center for Multiple Sclerosis Treatment and Research, Department of Neurology, Cleveland Clinic Foundation, OH 44106, USA. rudickr@cesmtp.ccf.org
PMID:
10426358
DOI:
10.1016/s0165-5728(99)00077-6
No abstract available
Publication types
Review
MeSH terms
Brain / pathology
Humans
Magnetic Resonance Imaging
Multiple Sclerosis / pathology
Multiple Sclerosis / therapy*
Patient Selection*
Recurrence
Time Factors